A multi-center randomized phase II clinical study of bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for Chinese patients with metastatic colorectal cancer - Concepedia

Concepedia

Publication | Closed Access

A multi-center randomized phase II clinical study of bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for Chinese patients with metastatic colorectal cancer

53

Citations

12

References

2014

Year

Ranhua Cao, Shuai Zhang, Dedong Ma, Likuan Hu

Medical Oncology

Second-line TreatmentOncologyMedicineColorectal CancerMetastatic Colorectal CancerPharmacotherapyCancer TreatmentPharmacologyRadiation OncologyChinese Patients

References

	Year	Citations

Page 1